Life
FDA Issues Warning to Novo Nordisk Amid Lilly's Strategic Expansion in China
The FDA has issued a warning to Novo Nordisk regarding product safety, while Lilly is increasing its investment in China to bolster market presence.
Editorial Staff 26 days ago